Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Martin Meglasson > Profile

Martin Meglasson

Affiliations

  • Chief Scientific Officer at Bellerophon Therapeutics Inc. (BLPH), 2015-05-22
  • V-P, Discovery Research at Ligand Pharmaceuticals Inc (LGND), 2010-05-11
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
BLPH $8.40 712 $5,980.80 19,098 2015-05-20 Filing
BLPH $12.00 12,000 $144,000.00 18,386 2015-02-19 Filing
LGND $1.63 6,250 $10,187.50 102,250 2010-05-11 Filing